Clinical Trial Update: Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports on the long-term safety of insulin aspart used in the treatment of Type 1 diabetes. The study, sponsored by Novo Nord…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NovoLog (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED